Document Detail


Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion.
MedLine Citation:
PMID:  20083405     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Deficiency of thymidine kinase-2 (TK2) has been described in children with early onset fatal skeletal myopathy. TK2 is a mitochondrial deoxyribonucleoside kinase required for the phosphorylation of deoxycytidine and deoxythymidine and hence is vital for the maintenance of a balanced mitochondrial dNTP pool in post-mitotic tissues. We describe a patient with two novel TK2 mutations, which caused disease onset shortly after birth and death at the age of three months. One mutation (219insCG) generated an early stop codon, thus preventing the synthesis of a functional protein. The second mutation (R130W) resulted in an amino acid substitution, which caused a severe reduction (<3%) of TK2 enzyme activity. These two novel TK2 mutations cause an extremely severe phenotype with overwhelming central nervous system symptoms not commonly seen in patients with TK2-deficiency. We conclude that the severe clinical presentation in this patient was due to a virtual lack of mitochondrial TK2 activity.
Authors:
Nicole Lesko; Karin Naess; Rolf Wibom; Nicola Solaroli; Inger Nennesmo; Ulrika von D?beln; Anna Karlsson; Nils-G?ran Larsson
Related Documents :
14581685 - Classical mitochondrial phenotypes without mtdna mutations: the possible role of nuclea...
7599205 - Modelling the effects of age-related mtdna mutation accumulation; complex i deficiency,...
8673275 - Highly conserved nuclear copies of the mitochondrial control region in the desert locus...
11455195 - A novel mutation in the mitochondrial 16s rrna gene in a patient with melas syndrome, d...
12745655 - Factor v leiden detection by polymerase chain reaction-restriction fragment length poly...
7921355 - Genetic variation of microsatellite loci in a bottlenecked species: the northern hairy-...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-01-18
Journal Detail:
Title:  Neuromuscular disorders : NMD     Volume:  20     ISSN:  1873-2364     ISO Abbreviation:  Neuromuscul. Disord.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-17     Completed Date:  2010-06-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111470     Medline TA:  Neuromuscul Disord     Country:  England    
Other Details:
Languages:  eng     Pagination:  198-203     Citation Subset:  IM    
Copyright Information:
Copyright 2009 Elsevier B.V. All rights reserved.
Affiliation:
Department of Laboratory Medicine, Division of Metabolic Diseases, Karolinska Institutet, Stockholm, Sweden. Nicole.Lesko@karolinska.se
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Triphosphate / metabolism
Arginine / genetics
Child
Child, Preschool
DNA Mutational Analysis / methods
DNA, Mitochondrial / genetics*
Female
Genetic Predisposition to Disease*
Humans
Infant
Infant, Newborn
Male
Mitochondria / metabolism
Mitochondria, Muscle / genetics,  metabolism
Mitochondrial Diseases / mortality
Mitochondrial Encephalomyopathies / genetics*,  pathology
Muscle, Skeletal / metabolism,  pathology
Mutagenesis, Site-Directed / methods
Mutation / genetics*
Thymidine Kinase / genetics*
Tryptophan / genetics
Chemical
Reg. No./Substance:
0/DNA, Mitochondrial; 56-65-5/Adenosine Triphosphate; 73-22-3/Tryptophan; 74-79-3/Arginine; EC 2.7.1.-/thymidine kinase 2; EC 2.7.1.21/Thymidine Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1alpha inhibitors.
Next Document:  Phage WO of Wolbachia: lambda of the endosymbiont world.